Drug manufacturing

Debate over naming of biosimilars intensifies ahead of WHO meeting

Drug regulators have noticed a proliferating problem. Around the world various regional regulators are applying different naming conventions for biosimilars.…

3D printing: the future of manufacturing medicine?

As the pharmaceutical industry shifts from mass manufacture towards personalised medicine, 3D printing could become part of the drug production line.…

Modified yeasts could be used to produce alkaloid drugs

Yeast has been genetically modified to make (S)-reticuline, a precursor to a wide range of therapeutic alkaloids. The work marks an important step towards producing such pharmaceuticals by fermentation.…

Pharmaceutical fakes: a dangerous pandemic

A unified authentication system is needed to combat the massive trade in counterfeit medicines. …

FDA fights opioid abuse with industry guidance

Measures to limit the abuse of opioid drugs have been issued by the US Food and Drug Administration in guidance for the pharmaceutical industry.…

Preparation for regulatory inspections

‘Rules and guidance for pharmaceutical distributors 2015’.…

FDA takes legal action against compounding pharmacy

The US Food and Drug Administration has taken legal action to prevent a compounding pharmacy from manufacturing or holding sterile drugs.…

How the pharmaceutical industry is contributing to antimicrobial resistance

Through poor practices, the pharmaceutical industry is adding to the problem of antimicrobial resistance instead of helping to solve it.…

How pharmacists can start a career in the pharmaceutical industry

Have you ever thought about going into the pharmaceutical industry but don’t know where to start? Emma Page finds out what you need to know.…

UK minor ailments scheme is a ‘no brainer’, says PSNC’s Sue Sharpe

Delegates attending the Sigma conference in Aamby Valley City, India — including community pharmacists, pharmacy owners and manufactures — want to see a national minor ailments scheme for the UK.…